Day-to-Day Management and Your Care Team
At a Glance
SANDO syndrome has no single treatment that fixes the underlying genetic problem, so care focuses on a coordinated team that supports balance, swallowing, speech, vision, mobility, and safety while monitoring complications and supplement risks.
Managing SANDO syndrome requires a shift from looking for a single cure to building a comprehensive, supportive care system. Because the syndrome affects multiple parts of your body—including your nerves, muscles, and brain—your care should be managed by a multidisciplinary team [1][2]. This team works together to monitor progression, maintain your physical function, and prevent complications like nutritional deficiencies or lung infections [2][3].
Building Your Care Team
A “one-doctor” approach is rarely enough for SANDO. Depending on your needs, a standard care team often includes:
- Neurologist: Ideally a specialist in mitochondrial medicine or neuromuscular disorders who can coordinate the care of POLG-related symptoms [4][2].
- Neuro-ophthalmologist: To monitor ptosis (drooping eyelids) and ophthalmoparesis (limited eye movement), and to check for any changes in retinal health [5][6].
- Speech-Language Pathologist (SLP): To evaluate your speech (dysarthria) and, more importantly, your ability to swallow safely (dysphagia) [7][8].
- Physical and Occupational Therapists: To help manage balance issues, prescribe appropriate mobility aids, and maintain your independence in daily tasks [9][10].
- Hepatologist and Cardiologist: Specialists may be added to monitor liver function or heart health, as POLG mutations can sometimes affect these organs [11][3].
Managing Daily Symptoms
While there are no medications that “fix” the underlying genetic mutation, several therapies can help you live better with SANDO.
Balance and Mobility
Sensory ataxia makes you feel unsteady because your brain isn’t getting clear position signals from your peripheral nerves [9].
- Neurologic Rehabilitation: A physical therapist can teach you strategies to compensate for balance loss using your vision. If testing shows inner-ear deficits, they may also prescribe vestibular rehabilitation [9].
- Safety Assessments: Working with an occupational therapist can help you identify fall risks in your home. Do not purchase mobility aids like weighted walkers or walking poles without therapist assessment, as the wrong equipment can increase fatigue or instability [10].
Swallowing and Speech
Difficulty swallowing (dysphagia) is one of the most important symptoms to manage, as it can lead to aspiration pneumonia—a serious condition where food or liquid enters the lungs [7][3].
- SLP Evaluation: If you experience coughing with meals, a wet voice, or unexplained weight loss, an SLP will often perform a videofluoroscopy (VFSS) or FEES test to see exactly where the muscles are struggling [7].
- Modification Strategies: Do not attempt to change your food texture or use “chin-tuck” postures without an SLP’s guidance, as these strategies can worsen airway protection in some people. Your SLP will prescribe the specific postures and diets that are safe for you [7].
Vision and Ptosis
If your eyelids droop significantly (ptosis), it can block your vision and cause you to tilt your head back to see, leading to neck pain [5].
- Ptosis Crutches: These are small attachments for your glasses that gently hold the eyelid open without surgery.
- Surgical Warning: While surgery can lift the eyelids, it is often more complex for SANDO patients [12]. Mitochondrial disease can make it harder for the eyes to close fully after surgery, and the anesthesia used during any operation must be carefully managed [12].
The Role of “Mitochondrial Cocktails”
Many patients with mitochondrial disease use a combination of supplements often called a mitochondrial cocktail, typically including Coenzyme Q10 (CoQ10), Riboflavin (Vitamin B2), and L-carnitine [13].
Current research on these supplements in POLG-related disease is very limited [14]. While some patients report subjective improvements in energy, there is no strong clinical evidence that these cocktails can reverse or stop the progression of SANDO [13][14].
Important Note: Supplements are not “risk-free.” They can interact with other medications or affect your liver and kidneys [15]. You should never self-start high doses; always have your mitochondrial team review your supplement list to ensure they are safe for your specific health profile [16][15].
Common questions in this guide
Which specialists are usually involved in SANDO syndrome care?
How can I manage balance problems and reduce falls with SANDO syndrome?
What should I do if SANDO syndrome causes swallowing problems?
Do mitochondrial cocktails treat or stop SANDO syndrome?
Is eyelid surgery safe for people with SANDO syndrome?
Get notified when new evidence is published on Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.
Parikh S, Goldstein A, Karaa A, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(12)) doi:10.1038/gim.2017.107.
PMID: 28749475 - 2
[An interpretation of the expert consensus on standards for the management of patients with primary mitochondrial disease from the Mitochondrial Medicine Society].
Guo Y, Hong SQ, Jiang L
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2018; (20(11)):887-892.
PMID: 30477617 - 3
Characterization of Factors Associated With Death in Deceased Patients With Mitochondrial Disorders: A Multicenter Cross-Sectional Survey.
Ivaniuk A, Anselm IA, Bowen A, et al.
Neurology 2025; (104(4)):e209779 doi:10.1212/WNL.0000000000209779.
PMID: 39883904 - 4
Adjunctive transcranial DC stimulation in the management of refractory drug-resistant focal epilepsy in POLG mitochondrial disease: A case series.
Bangel KA, Ng Y, Lim A, et al.
Seizure 2026; doi:10.1016/j.seizure.2026.05.009.
PMID: 42248710 - 5
Rod bipolar cell dysfunction in POLG retinopathy.
Sanderson KG, Millar E, Tumber A, et al.
Documenta ophthalmologica. Advances in ophthalmology 2021; (142(1)):111-118 doi:10.1007/s10633-020-09777-w.
PMID: 32567010 - 6
Ophthalmological findings in 74 patients with mitochondrial disease.
Zhu CC, Traboulsi EI, Parikh S
Ophthalmic genetics 2017; (38(1)):67-69 doi:10.3109/13816810.2015.1130153.
PMID: 27029465 - 7
Speech and swallowing abnormalities in adults with POLG associated ataxia (POLG-A).
Vogel AP, Rommel N, Oettinger A, et al.
Mitochondrion 2017; (37()):1-7 doi:10.1016/j.mito.2017.06.002.
PMID: 28634151 - 8
Dysarthria and dysphagia in patients with mitochondrial diseases.
Kuin REM, Groothuis JT, Buit P, et al.
Molecular genetics and metabolism 2024; (142(3)):108510 doi:10.1016/j.ymgme.2024.108510.
PMID: 38843620 - 9
Bilateral Vestibulopathy Aggravates Balance and Gait Disturbances in Sensory Ataxic Neuropathy, Dysarthria, and Ophthalmoparesis: A Case Report.
van Leeuwen RB, Smits BW, Rodenburg RJ, van Engelen BG
Journal of clinical neuromuscular disease 2016; (18(1)):34-6 doi:10.1097/CND.0000000000000126.
PMID: 27552387 - 10
Rehabilitation challenges and progress in a patient with sensory ataxic Guillain-Barré syndrome: a case report.
Kinoshita T, Kawasaki S, Furotani Y, et al.
Physiotherapy theory and practice 2026; (42(10)):1340-1347 doi:10.1080/09593985.2026.2635043.
PMID: 41717799 - 11
Juvenile/adult-onset POLG-related disease unmasked by valproate-associated fulminant hepatic failure.
Mathavan A, Rathi K, Mundhra LJ, Mathavan A
BMJ case reports 2025; (18(12)) doi:10.1136/bcr-2025-269373.
PMID: 41381198 - 12
Peri-operative management of an adult with POLG-related mitochondrial disease.
Valent A, Delorme L, Roland E, et al.
Anaesthesia reports 2022; (10(1)):e12159 doi:10.1002/anr3.12159.
PMID: 35309182 - 13
Mitochondrial disease patients' perception of dietary supplements' use.
Karaa A, Kriger J, Grier J, et al.
Molecular genetics and metabolism 2016; (119(1-2)):100-8.
PMID: 27444792 - 14
Headache in mitochondrial diseases: From migraine to stroke-like episodes.
Azzimonti M, Padelli S, Ronchi D, et al.
Headache 2026; doi:10.1111/head.70180.
PMID: 42452951 - 15
Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus.
De Vries MC, Brown DA, Allen ME, et al.
Journal of inherited metabolic disease 2020; (43(4)):800-818 doi:10.1002/jimd.12196.
PMID: 32030781 - 16
Evidence for sodium valproate toxicity in mitochondrial diseases: a systematic analysis.
Ratnaike TE, Elkhateeb N, Lochmüller A, et al.
BMJ neurology open 2024; (6(1)):e000650 doi:10.1136/bmjno-2024-000650.
PMID: 38860231
This page is for informational purposes only and does not constitute medical advice. Your neurologist and multidisciplinary care team should guide decisions about supplements, swallowing strategies, mobility aids, and treatment for SANDO syndrome.